Luc Marcelis
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- HIV/AIDS Research and Interventions
Papers in
-
- Prostate Cancer Treatment and Research 1
- Oncology 2
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- J. Sonnet (3 shared papers)J. Dasnoy (2 shared papers)Henri Taelman (2 shared papers)Michel Vanhaeverbeek (2 shared papers)Philippe Van de Perre (1 shared paper)Marc De Bruyère (1 shared paper)Henri Noël (1 shared paper)Nathan Clumeck (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)European Journal of Cancer (1 paper)Journal of Clinical Pathology (1 paper)New England Journal of Medicine (1 paper)Current Pharmaceutical Design (1 paper)
- Partner nations
- Belgium
In The Last Decade
Luc Marcelis
8 papers receiving 357 citations
Peers
Comparison fields: 5 of 67
- Virology 78
- Infectious Diseases 93
- Immunology 85
- Epidemiology 121
- Agronomy and Crop Science 39
Countries citing papers authored by Luc Marcelis
This map shows the geographic impact of Luc Marcelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Marcelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Marcelis more than expected).
Fields of papers citing papers by Luc Marcelis
This network shows the impact of papers produced by Luc Marcelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Marcelis. The network helps show where Luc Marcelis may publish in the future.
Co-authors
The 25 scholars most cited alongside Luc Marcelis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 207 | |
| 2 | 2008 | 62 | |
| 3 | 2012 | 57 | |
| 4 | 1987 | 36 | |
| 5 | 1988 | 17 | |
| 6 | [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients]. | 1988 | 6 |
| 7 | 1981 | 4 | |
| 8 | 2024 | 3 |
About Luc Marcelis
Luc Marcelis is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Immunology and Infectious Diseases, having authored 8 papers that have together received 392 indexed citations. Recurring topics across this work include Trypanosoma species research and implications (2 papers), T-cell and Retrovirus Studies (2 papers), Intraperitoneal and Appendiceal Malignancies (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Prostate Cancer Treatment and Research (1 paper), Antifungal resistance and susceptibility (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Virology (78 citations), Infectious Diseases (93 citations), Immunology (85 citations), Epidemiology (121 citations) and Agronomy and Crop Science (39 citations). Luc Marcelis has collaborated with scholars based in Belgium. Frequent co-authors include J. Sonnet, J. Dasnoy, Henri Taelman, Michel Vanhaeverbeek, Philippe Van de Perre, Marc De Bruyère, Henri Noël, Nathan Clumeck, L Eyckmans and Jean‐Paul Butzler. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Journal of Clinical Pathology, New England Journal of Medicine and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.